COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,384 Articles (22,816 medRxiv, 8,568 bioRxiv)

Most recent first Previous |  Page 2256: Articles 22551-22560  | Next

Modeling the Spread and Control of COVID-19
Trivedi, A., Sreenivas, N. K., Rao, S.
10.1101/2020.09.16.20195826 — Posted: 2020-09-18 Discussion: Onsite
Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America
Prats-Uribe, A., G. Sena, A., Yin Hui Lai, L., Ahmed, W.-U.-R., Alghoul, H., Alser, O., Alshammari, T. M., Areia, C., Carter, W., Casajust, P., Dawoud, D., Golozar, A., Jonnagaddala, J., Mehta, P., Menchung, G., Morales, D. R., Nyberg, F., Posada, J. D., Recalde, M., Roel, E., Shah, K., Shah, N., Schilling, L. M., Subbian, V., Vizcaya, D., Zhang, L., Zhang, Y., Zhu, H., Liu, L., Rijnbeek, P., Hripcsak, G., Lane, J. C. E., Burn, E., Reich, C., Suchard, M. A., Duarte-Salles, T., Kosta, K., Ryan, P. B., PRIETO-ALHAMBRA, D.
10.1101/2020.09.15.20195545 — Posted: 2020-09-18
COVID-19 epidemic modelling and the effect of publichealth interventions in India- SEIQHRF model
Sengupta, P., Ganguli, B., Chatterjee, A., SenRoy, S., Chatterjee, M.
10.1101/2020.09.16.20182915 — Posted: 2020-09-18
Proteomics identifies a type I IFN, prothrombotic hyperinflammatory circulating COVID-19 neutrophil signature distinct from non-COVID-19 ARDS
Reyes, L., Sanchez-Garcia, M. A., Morrison, T., Howden, A. J., Watts, E. R., Arienti, S., Sadiku, P., Coelho, P., Mirchandani, A. S., Hope, D., Clark, S. K., Singleton, J., Johnston, S., Grecian, R., Poon, A., McNamara, S., Harper, I., Fourman, M. H., Brenes, A. J., Pathak, S., Lloyd, A., Rodriguez Blanco, G., Von Kriegsheim, A., Ghesquiere, B., Vermaelen, W., Cologna, C. T., Dhaliwal, K., Hirani, N., Dockrell, D., Whyte, M. K., Griffith, D. M., Cantrell, D. A., Walmsley, S. R.
10.1101/2020.09.15.20195305 — Posted: 2020-09-18 Discussion: Offsite
A Cost/Benefit Analysis of Clinical Trial Designs for COVID-19 Vaccine Candidates
Berry, D., Berry, S., Hale, P., Isakov, L., Lo, A., Siah, K. W., Wong, C. H.
10.1101/2020.09.15.20195495 — Posted: 2020-09-18
Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: A test negative design
Stowe, J., Tessier, E., Zhao, H., Guy, R., Muller-Pebody, B., Zambon, M., Andrews, N., Ramsay, M., Lopez Bernal, J.
10.1101/2020.09.18.20189647 — Posted: 2020-09-18
Superspreaders provide essential clues for mitigation of COVID-19
Nielsen, B. F., Sneppen, K.
10.1101/2020.09.15.20195008 — Posted: 2020-09-18 Discussion: Onsite
COVID-19 Case-Age Distribution: Correction for Differential Testing by Age
Fisman, D., Greer, A., Hillmer, M., O'Brien, S., Drews, S. J., Tuite, A.
10.1101/2020.09.15.20193862 — Posted: 2020-09-18
Clinical Thrombosis Rate was not Increased in a Cohort of Cancer Patients with COVID-19
Zavras, P. D., Kabarriti, R., Mehta, V., Goel, S., Billett, H. H.
10.1101/2020.09.15.20195263 — Posted: 2020-09-18
Longitudinal multi-omics analysis identifies responses of megakaryocytes, erythroid cells and plasmablasts as hallmarks of severe COVID-19 trajectories
Bernardes, J. P., Mishra, N., Tran, F., Bahmer, T., Best, L., Blase, J. I., Bordoni, D., Franzenburg, J., Geisen, U., Josephs-Spaulding, J., Koehler, P., Kuenstner, A., Rosati, E., Aschenbrenner, A. C., Bacher, P., Baran, N., Boysen, T., Brandt, B., Bruse, N., Doerr, J., Draeger, A., Elke, G., Ellinghaus, D., Fischer, J., Forster, M., Franke, A., Franzenburg, S., Frey, N., Friedrichs, A., Fuss, J., Glueck, A., Hamm, J., Hinrichsen, F., Hoeppner, M. P., Imm, S., Juenker, R., Kaiser, S., Kan, Y. H., Knoll, R., Lange, C., Laue, G., Lier, C., Lindner, M., Marinos, G., Markewitz, R., Nattermann, J., Noth, R., Pickkers, P., Rabe, K. F., Renz, A., Roecken, C., Rupp, J., Schaffarzyk, A., Scheffold, A., Schulte-Schrepping, J., Schunck, D., Skowasch, D., Ulas, T., Wandinger, K.-P., Wittig, M., Zimmermann, J., Busch, H., Hoyer, B. F., Kaleta, C., Heyckendorf, J., Kox, M., Rybniker, J., Schreiber, S., Schultze, J., Rosenstiel, P., HCA Lung Biological Network, , Deutsche COVID-19 Omics Initiative (DeCOI)
10.1101/2020.09.11.20187369 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).